Experiences of a “COVID protected” robotic surgical centre for colorectal and urological cancer in the COVID-19 pandemic
Journal of Robotic Surgery · 2022-02 · 16 (1) · 59-64
DOI: 10.1007/s11701-021-01199-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Robotic Surgery, online erschienen am 11.02.2021. Verfasst von Jeremy R Huddy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Colorectal Surgery, Frimley Park Hospital, Camberley, UK. Hauptthemen laut MEDLINE: COVID-19, Laparoscopy, Rectal Neoplasms, Robotic Surgical Procedures. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The recent COVID-19 pandemic led to the cancellation of elective surgery across the United Kingdom. Re-establishing elective surgery in a manner that ensures patient and staff safety has been a priority. We report our experience and patient outcomes from setting up a “COVID protected” robotic unit for colorectal and renal surgery that housed both the da Vinci Si (Intuitive, Sunnyvale, CA, USA) and the Versius (CMR Surgical, Cambridge, UK) robotic systems. “COVID protected” robotic surgery was undertaken in a day-surgical unit attached to the main hospital. A standard operating procedure was developed in collaboration with the trust COVID-19 leadership team and adapted to national recommendations. 60 patients underwent elective robotic surgery in the initial 10-weeks of the study. This included 10 colorectal procedures and 50 urology procedures. Median length of stay was 4 days for rectal cancer procedures, 2 days less than prior to the COVID period, and 1 day for renal procedures. There were no instances of in-patient coronavirus transmission. Six rectal cancer patients waited more than 62 days for their surgery because of the initial COVID peak but none had an increase T-stage between pre-operative staging and post-operative histology. Robotic surgery can be undertaken in “COVID protected” units within acute hospitals in a safe way that mitigates the increased risk of undergoing major surgery in the current pandemic. Some benefits were seen such as reduced length of stay for colorectal patients that may be associated with having a dedicated unit for elective robotic surgical services.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Colorectal Surgery, Frimley Park Hospital, Camberley, UK.
- Department of Surgery & Cancer, Imperial College London, London, UK.
- Frimley Renal Cancer Centre, Frimley Park Hospital, Camberley, UK.
- Department of Colorectal Surgery, Frimley Park Hospital, Camberley, UK. henry.tilney@nhs.net.
Zitieren
APA
Huddy, J. R., Crockett, M., Nizar, A. S., Smith, R., Malki, M., Barber, N., & Tilney, H. S. (2022). Experiences of a “COVID protected” robotic surgical centre for colorectal and urological cancer in the COVID-19 pandemic. Journal of Robotic Surgery, 16(1), 59-64. https://doi.org/10.1007/s11701-021-01199-3
Vancouver
Huddy JR, Crockett M, Nizar AS, Smith R, Malki M, Barber N, et al. Experiences of a “COVID protected” robotic surgical centre for colorectal and urological cancer in the COVID-19 pandemic. Journal of Robotic Surgery. 2022;16(1):59-64. doi:10.1007/s11701-021-01199-3
BibTeX
@article{Huddy2022,
author = {Huddy, Jeremy R and Crockett, Matthew and Nizar, A Shiyam and Smith, Ralph and Malki, Manar and Barber, Neil and Tilney, Henry S},
title = {Experiences of a “COVID protected” robotic surgical centre for colorectal and urological cancer in the COVID-19 pandemic},
journal = {Journal of Robotic Surgery},
year = {2022},
volume = {16},
number = {1},
pages = {59--64},
doi = {10.1007/s11701-021-01199-3}
}
EUVIMED